Premium
X‐linked dominant protoporphyria: a new porphyria
Author(s) -
Seager M. J.,
Whatley S. D.,
Anstey A. V.,
Millard T. P.
Publication year - 2014
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.12202
Subject(s) - erythropoietic protoporphyria , porphyria , protoporphyrin , dermatology , phenotype , disease , medicine , incidence (geometry) , bloodletting , ferrochelatase , genetics , pathology , biology , heme , gene , biochemistry , alternative medicine , porphyrin , physics , optics , enzyme
Summary X‐linked dominant protoporphyria ( XLDPP ) was first reported in the genetics literature in 2008. It has a phenotype very similar to erythropoietic protoporphyria ( EPP ), but is distinguished from EPP by higher concentrations of erythrocyte protoporphyrin (of which a high proportion is zinc‐chelated), its apparently higher incidence of liver disease, and an X ‐linked dominant pattern of inheritance. Dermatologists should understand how XLDPP differs from EPP , in order to advise newly diagnosed patients correctly about the genetic implications and the long‐term management strategy. We present a case series of XLDPP to introduce this condition to the dermatology literature.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom